Cargando…
Effects of Incretin Therapy on Skeletal Health in Type 2 Diabetes—A Systematic Review
Diabetes poses a significant risk to bone health, with Type 1 diabetes (T1D) having a more detrimental impact than Type 2 diabetes (T2D). The group of hormones known as incretins, which includes gastric inhibitory peptide (GIP) and glucagon‐like peptide 1 (GLP‐1), play a role in regulating bowel fun...
Autores principales: | Viggers, Rikke, Rasmussen, Nicklas Højgaard‐hessellund, Vestergaard, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652182/ https://www.ncbi.nlm.nih.gov/pubmed/38025038 http://dx.doi.org/10.1002/jbm4.10817 |
Ejemplares similares
-
Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Danish Nested Case-Control Study
por: Viggers, Rikke, et al.
Publicado: (2021) -
The Efficacy of Alendronate Versus Denosumab on Major Osteoporotic Fracture Risk in Elderly Patients With Diabetes Mellitus: A Danish Retrospective Cohort Study
por: Viggers, Rikke, et al.
Publicado: (2022) -
Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Kim, Je-Yon, et al.
Publicado: (2016) -
Incretin hormones and type 2 diabetes
por: Nauck, Michael A., et al.
Publicado: (2023) -
The evolving place of incretin-based therapies in type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2010)